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1. Introduction
The last two centuries of industrialization, urbanization and changes in land use converting
agricultural and natural areas to artificial surface have led to European plants being considered
amongst the most threatened in the world. In some countries, more than two-thirds of the
existing habitat types are considered endangered. Human activity is the primary cause of risk
for 83% of endangered plant species. Habitat destruction and loss are also a problem because
they lead to the fragmentation of the remaining habitat resulting in futher isolation of plant
population [1]. From another side during the last 10 years an intense interest has emerged in
"nutraceuticals" (or "functional foods") in which phytochemical constituents can have long-
term health promoting or medicinal qualities. Although the distinction between medicinal
plants and nutraceuticals can sometimes be vague, a primary characteristic of the latter is that
nutraceuticals have a nutritional role in the diet and the benefits to health may arise from long-
term use as foods (i.e. chemoprevention) [2]. In contrast, many medicinal plants possess
specific medicinal benefits without serving a nutritional role in the human diet and may be
used in response to specific health problems over short- or long-term intervals [3].
There is indisputable interest towards traditional and alternative medicine world-wide [4] and
at the same time an increasing application of herbs in medical practices, reported by World
Health Organization (WHO) [5]. Nowadays the centuries-old tradition of medicinal plants
application has turned into a highly profitable business on the world market. Numerous herbal
products have been released like patented medical goods, food additives, herbal teas, extracts,
essential oils, etc [6 - 9].
There is an expansion of the market of herbs and herbs based medical preparations all over
the world. The income a decade ago in the North American market for sales of medicinal plants
has climbed to about $3 billion/year [10]. In South America, Brazil is outstanding with 160
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millions USD for 2007 while in Asia, China is at the leading trade position with 14 billions USD
for 2005, etc. [11]. Similar increase was observed in Western Europe with 6 billion USD income
for a period of two years from 2003 to 2004. The sales increased in Czech Republic by 22 %
from 1999 to 2001 and jumped twice in Bulgaria [12].
Medicinal plants are precious part of the world flora. More than 80 000 species out of the
2 500 000 higher plants on Earth are reported to have at least some medicinal value and
around 5 000 species have specific therapeutic value. The contemporary phytotherapy and
the modern allopathic  medicine use raw materials  from more than 50 000 plant  species
[13].  About  two  thirds  of  these  fifty  thousand  plants  utilized  in  the  pharmacological
industry are harvested from nature [14].  Small portions like 10%-20% of the plants used
for remedies preparations are cultivated in fields or under controlled conditions [15]. Ages-
old exploitation of the natural resources and the dramatically increased interest are a real
thread for  the  biological  diversity.  Bad harvesting management  and insufficient  cultiva‐
tion practices  may lead to  extinction of  endangered species  or  to  destruction of  natural
resources. Science has already recorded diminishing natural populations, lost in the genetic
diversity, local extinction of many species and/or degeneration of their natural habitats [16].
This alarming situation is raising the questions about special efforts which should be paid
both to protection of the plant populations and to up-to-date knowledge concerning more
reasonable and effective utilization of these plants [12].
Bulgaria as a country with a rich and diverse flora (comprising of 7 835 species) and with old
traditions in herbs’ use faces the same global problems. One of the most serious challenges is
the control and the limitation of the expanding gathering of endangered medicinal plants [17].
The Biodiversitry Act covers Sideritis scardica (mursala tea), Alchemilla vulgaris, Acorus cala‐
mus, Rhodiola rosea, Leucojum aestivum, Gentiana sp., Glycyrrhiza glabra, Ruta graveolens, and some
medicinal plants under special rules of protection and use e.g. Inula helenium, Carlina acanthi‐
folia, Berberis vulgaris, Rhammus frangula, Rubia tinctorum, Atropa belladona, Origanum heracleo‐
ticum etc. More than 750 herbs are used in the folk medicine while 150 - 250 are used in the
official medicine and can be found at the market [18 - 20]. A considerable number of the wild
species are rare, endangered or under protection [21, 22], and 12.8% are endemics [23]. Recently
120 herbs have been traditionally collected from their natural populations, 47 are under
protection, 38 are included in the Red Data Book of Bulgaria, 60 have been cultivated, 35 are
main industrial crops [24]. Bulgarian medicinal plants are famous for their high content of
biologically active substances. Their high value qualities are due to the unique combinations
of specific soil and climatic conditions in the different sites of the country [25]. Bulgaria is the
European leader in herbs export and occupies the 8th world position with trade in 40 countries
all over the world. The greatest export of 50% is to Germany being 3 600 tones in 1991 and
doubling to 6 000 tones in 2 000 [8]. Spain, Italy, France, Austria and USA are also major trade
partners. The export is increasing steadily from 6 - 7 t in 1992 to 12 tones in 2000 – 2003, to 15
- 17 000 tones in 2007 [22, 26 - 28,]. These amounts represented about 70% - 80% out of all
harvested and processed medicinal plants in Bulgaria [27]. The bigger number of these species
is wild growing [29] but recently cultivation in fields has been applied as a measure to protect
Environmental Biotechnology - New Approaches and Prospective Applications236
medicinal plants included in the list of protected species. At present about 20% of the medicinal
plants are cultivated, but this share comprises about 40% of the export [24].
Worldwide the constant expansion of herbs’ trade, the insufficient cultivation fields, and the
bad management of harvesting and overharvesting have led to exhaustion of the natural
resources and reduction of the biodiversity. According to the data of the Food and Agricultural
Organization (FAO) at the United Nations annually the flora bares irretrievable losses which
destroy the natural resources and the ecological equilibrium [30]. Four thousand to 10 000
medicinal species were endangered of disappearing at the beginning of this century [14]. To
stop the violence against nature, efforts should be directed both to preservation of the plant
populations and to elevating the level of knowledge for sustainable utilization of these plants
in traditional, alternative, and allopathic medicine [12].
This great issue is in the focus of science which offers different decisions to solve the global
problem. Cultivation of the valuable species in experimental conditions is one of the ap‐
proaches. The latter refers to application of classical methods for multiplication by cuttings,
bulbs, and so forth, as well as by biotechnological methods of in vitro cultures and clonal
propagation for production of enormous number of identical plants. The micropropagation is
considered to have the greatest commercial and iconomical importance for the rapid propa‐
gation and ex situ conservation of rare, endemic, and endangered medicinal plants [31 - 34].
Except for clonal multiplication and maintaining the genetic structure biotechnology is
powerful for modifying genetic information and gene expression to obtain new valuable
compounds with new properties or with increased amounts [35 - 37]. Micropropagation, cell
and callus cultures, metabolic engineering and genetic manipulations are especially appro‐
priate for species which are difficult to propagate in vivo [36].
In Bulgaria quite successful investigations have been performed for in vitro clonal multiplica‐
tion of valuable, endemic, rare and endangered medicinal species: Rhodiola rosea, Gentiana lutea,
Sideritis scardica, Pancratium maritimum, Scabiosa argentea, Cionura erecta, Jurinea albicaulis subsp.
kilaea, Peucedanum arenarium, Linum tauricum subsp. bulgaricum, Aurinia uechtritziana, Silene
thymifolia, Glaucium flavum, Stachys maritima, Astrodaucus littoralis, Otanthus maritimus, Plantago
arenaria, Verbascum purpureum, Alchemilla sps, etc. [38 - 44]
More than 2 000 different species are used in Europe for production of medicinal and other
herbal preparations. Seventy percents of these species are growing in wild nature [17, 29] with
already limiting resources which demands search for alternative methods friendly to nature.
Biotechnological methods seem appropriate ones with their potential for multiplication,
selection and protection of medicinal plants. In this respect biotechnological approaches are
convenient for use of cells, tissue, organs or entire organism which grow and develop in in
vitro controlled conditions, and can be subjected to in vitro and genetic manipulations [33] to
obtain desired substances [45]. These methods are especially appropriate and reasonable to
apply when the targeted species have high economical or trade value, or plant resources are
limited concerning the availability of wild area or good healthy plants, or when the plants are
difficult to grow [46, 47].
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In vitro cultivation may be directed to development of different systems depending on the
practical needs. At present production of a large number of identical plants by clonal micro‐
propagation is the most prominent one. Complex and integrated approaches for cultivation
of plant systems may be the basis for future development of new, effective, safe and high
quality products. These scientific achievements might be used for the establishment of ex
situ and in vitro collections, multiplication of desired species and to obtain raw material for the
pharmaceutical and cosmetic industries [48]. In vitro technologies offer some or most of the
following advantages: easier extractions and purification of valuable substances from tempo‐
rary sources; new products which may not be found in nature; absence of various environ‐
mental and seasonal effects, automation, better control of the biosynthetic pathways and
flexibility in obtaining desired product; shorter production cycles and cheaper less costly
products. Here should also be mentioned the potential of the sophisticated techniques of
genetic engineering, which might be applied respecting the rules of contained use [33; 47]. At
present the methods of plant cell and tissue cultures have found many proper sites for
application in the medicinal plants utilization. The achieved results and the confidence for
further success drive the efforts for wider application of plant biotechnologies in more spheres
concerning medicinal plants [37].
2. Essence of in vitro culture
Plant cell methods and techniques were initially used in fundamental scientific investiga‐
tions at the beginning of their development in the early 60-ties of the last century. Plant
biotechnology is based on the totypotence of the plant cell [35; 49]. This process of de novo
reconstruction of  an organism from a cell  in  differentiated stage is  highly linked to the
process  of  dedifferentiation  when  the  cell  is  returning  back  to  its  early  embryogenic/
meristematic  stage.  In this  stage cells  undergo division and may form nondifferentiated
callus  tissue  or  may redifferentiate  to  form new tissue,  organs  and an entire  organism.
Morphogenesis in vitro is realized via two major pathways: (i) organogenesis when a group
of cells is involved for de novo formation of organs and (ii) somatic embryogenesis when
the new organism is initiated from a single cell.
3. Micropropagation
Micropropagation is a vegetative propagation of the plants in vitro conditions (in glass vessels
under controlled conditions) leading to development of numerous plants from the excised
tissue and reproducing the genetic potential of the initial donor plant.
Usually tissues containing meristematic cells are used for induction of axilary or adventitious
shoots but induction of somatic embryos can be achieved from differentiated cells as well.
Micropropagation is used routinely for many species to obtain a large number of plants with
high quality. It is widely applied to agricultural plants, vegetable and ornamental species, and
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in some less extent to plantation crops. One of the substantial advantages of micropropagation
over traditional clonal propagation is the potential of combining rapid large-scale propagation
of new genotypes, the use of small amounts of original germplasm (particularly at the early
breeding and/or transformation stage, when only a few plants are available), and the genera‐
tion of pathogen-free propagules. [50]. Compared to the other spheres of in vitro technologies
clonal propagation has proved the greatest economical and market importance in industry
including pharmaceutical industry which needs for raw material from the medicinal plants is
increasing constantly. It offers faster and alternative way for production of raw material and
from another side overcoming the problems arising from the limited natural resources.
At present, there is a long list of research groups worldwide investigating hundreds of
medicinal species. Various success procedures and recipes for many of these species have been
developed. However, there is not a universal protocol applicable to each species, ecotype, and
explant tissue. From another side all these continuous tedious studies on the standardization
of explant sources, media composition and physical state, environmental conditions and
acclimatization of in vitro plants have accumulated information, continuously enriched, which
is a good basis for elaboration of successful protocols for more species. Wider practical
application of micropropagation depends on reduction of costs so that it can become compa‐
tative with seed production or traditional vegetative propagation methods (e.g., cuttings,
tubers and bulbs, grafting) [50].
4. Metabolic engineering and biotransformation
The plant cell culture systems have potential for commercial exploitation of secondary
metabolites. Similar to the fermentation industry using microorganisms and their enzymes
[35, 51, 52] to obtain a desired product plant cells are able to biotransform a suitable substrate
compound to the desired product. The latter can be obtained as well by addition of a precursor
(a particular compound) into the culture medium of plant cells. In the process of biotransfor‐
mation, the physicochemical and biological properties of some natural products can be
modified [53]. Thus, biotransformation and its ability to release products into the cells or out
of them provide an alternative method of supplying valuable natural products that occur in
nature at low levels. Generally, the plant products of commercial interest are secondary
metabolites, which in turn belong to three main categories: essential oils, glycosides and
alkaloids [51]. Plant cell cultures as biotransformation systems have been highlighted for
production of pharmaceuticals but other uses have also been suggested as new route for
synthesis, for products from plants difficult to grow, or in short supply, as a source of novel
chemicals. It is expected that the use, production of market price and structure would bring
some of the other compounds to a commercial scale more rapidly and in vitro culture products
may see further commercialization [54]. The application of molecular biology techniques to
produce transgenic cells and to effect the expression and regulation of biosynthetic pathways
is also a significant step towards making in vitro cultures more generally applicable to the
commercial production of secondary metabolites [54]. However, because of the complex and
incompletely understood nature of plant cells growing in in vitro cultures, case-by-case studies
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have been used to explain the problems occurring in the production of secondary metabolites
from cultured plant cells.
Genetic manipulations (direct and indirect genetic transformation) are other different
approaches to increase the content biological active substances in plants. Genetic engineering
covers a complex of methods and techniques applied to the genome in order to modify it to
obtain cells and organisms with improved qualities or possessing desired traits. These might
refer to better yield or resistance, as well as, to higher metabolite production or synthesis of
valuable biologically active substances [55]. Gene transfer may be direct when isolated desired
DNA fragments are inserted into the cell most often by electrical field or adhesion. This method
is less used in medicinal plants. Indirect genetic transformation of plants uses DNA vectors
naturally presenting in plant pathogens to transfer the isolated genes of interest and to trigger
special metabolic pathways [56]. Agrobacterium rhizogenes induces formation of "hairs" at the
roots of dicotyledonous plants. Genetically modified "hairy" roots produce new substances,
which very often are in low content. Hairy roots are characterized with genetic stability and
are potential highly productive source for valuable secondary metabolites necessary for the
pharmaceutical industry [57, 58]. Manipulations and optimization of the productivity of the
transformed hairy roots are usually the same as for the other systems for in vitro cultivation
[59]. They also depend on the species, the ecotype, the explant, the nutrient media, cultivation
conditions, etc [60].
All these application of the principles of plant cell division and regeneration to practical plant
propagation and further manipulations could be possible if there are reliable in vitro cultures,
which efficiency depends on many various factors.
5. Factors influencing cell growth in vitro
The ability of the plant cell to realize its totypotence is influenced in greatest extend by the
genotype, mother/donor plant, explant, and growth regulators what was confirmed by the
tedious empirical work of in vitro investigations [61, 62]. Here, some of the specific and most
important requirements will be mentioned in order of understanding the efforts and originality
of some ideas when establishing in vitro cultures of medicinal plants.
Genotypes. Morphogenetic potential of excised tissue subjected to cultivation in vitro is in strong
dependence of the genotype [63]. Genetically plants demonstrate different organogenic
abilities, which were observed for all plants groups including medicinal plants [64 - 72]. Some
of the species (like tobacco and carrot) are easy to initiate in in vitro cultures while others are
more difficult - reculcitrant (cereals, grain legumes, bulbous plants). Many of the wild species
like most of the medicinal plants and especially those producing phenols are more difficult or
extremely difficult to handle.
Donor plant. The donor plant should be healthy, in the first stages of its intensive growth, not
in dormancy. Rhyzomes and bulbs usually need pretreatment with low or high temperatures
for different periods of time [35, 73].
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Explant. The explant type might determine the organogenesis potential and the genetical
stability of the clonal material. Physiological age of the explant is also crucial. Immature organs
and differentiated cells excised from stem tips, axilary buds, embryos and other meristematic
tissues are the most appropriate [35, 62, 73]. However, despite the development of cell and
molecular biology the limits still exist in receiving easy information about the genetic,
epigenetic and physiological status of the explant. Empirical approach is the most common to
specify the chemical and physical stimuli triggering cell totypotence.
Nutrient media. Although more than 50 different media formulations have been used for the
in vitro culture of tissues of various plant species the formulation described by Murashige and
Skoog (MS medium) [74] is the most commonly used, often with relatively minor changes.
Other famous media are those of Gamborg [75; 76], Huang and Murashige [77] Nischt and
Nischt etc. The nutrient medium usually consists of all the essential macro- and micro salts,
vitamins, plant growth regulators, a carbohydrate, and some other organic substances if
necessary [62].
Plant growth regulators. Plant growth regulators, including the phytochormones, are essential
for cell dedifferentiation, division and redifferention leading to callus tissue and organ
formation. The auxins and cytokinins are the most important for in vitro development and
morphogenesis. However, the most appropriate plant regulators and their concentrations in
the nutrient media depend on the genotype, explants type and the donor plant physiological
status. Hence, numerous combinations could be designed and the optimal ones are validated
empirically. All that creates the difficulties of the experimental work, which is dedicated to
find the balance between the factors determining reliable in vitro development.
Cytokinins. Different groups of cytokinins might be used but the most efficient ones for
induction of organogenesis and a large number of buds are the natural cytokinins (zeatin and
kinetin) or the synthetic ones - 6-benzylaminopurine (benzyl adenine (BA, BAP), 6-γ(-
dimethylallyl-amino)-purine (2iP) and thidiazuron (TDZ).
Auxins. The auxins also are obtained from natural plant materials like indolyl-3-acetic acid
(IAA), indole 3-butyric acid (IBA), α- naphthyl acetic acid (NAA) or are chemically produced
like 2,4-dichlorophenoxyacetic acid (2,4-D), 2,4,5-trichlorophenoxyacetic acid (2,4,5-T),
picloram, etc. The auxins have a wide spectrum of effects on different processes of plant
development and morphogenesis. Depending on their chemical structure and concentration,
they induce or inhibit cell division, stimulate callus or root formation.
Gibberellins. The group of gibberellins includes more than 80 compounds, which stimulate cell
division and elongation. The most commonly used one is gibberellic acid (GA3).
Vitamins and supplements. Growth regulatory functions are attributed to some of the vitamins
B group – thiamine (B1), niacin (vit B3, nicotinic acid, vitamin PP), piridoxin (vit B6), which in
fact are the most popular for in vitro recipes. Supplements like yeast extract, coconut milk,
maize extract and some other might effect tissue growth and bud development.
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The best morphogenesis could be achieved when the optimal balance between the effect of
genotype, explant and growth regulators is identified.
6. Rooting, aclimatization and adaptation
The processes of root formation and adaptation have their specific requirements and not all of
the quoted cases of organogenesis, embryogenesis, regeneration are followed by rhizogenesis
and adaptation. These processes depend on the genotype and in most of the cases on the
ecotype of the species [62], whereas the necessary culture conditions are chosen in an empirical
way. The reduction of the sucrose from 2 % - 3% to 1% - 0.5% stimulates root induction and
formation. Aclimatization of the obtained in vitro plants is a critical moment for establishment
of good protocol for micropropagtion. Adaptation of plants in greenhouse, field or in the
nature is another delicate and difficult stage. Usually in in vitro conditions, regenerants formed
well-developed root system. However, they quickly loose their turgor after transfer to soil.
Their leaves withered and dried. These plants underwent stress due to the changes in humidity
and culture medium.
7. In vitro cultures conditions
The light, temperature and air humidity are important parameters for in vitro cultivation of
the plant cells and tissues. The light is one of the important factors for morphogenetic process
like bud and shoots formation, root induction and somatic embryogenesis. Light spectrum and
intensity as well as the photoperiod are very important for successful cultivation [78]. The
recommended temperature in the cultivation rooms or phytothrone chamber is about 23-25
°C but the cultures of tropical species require higher temperature (27-30°C), while arctic plants
cultures – lower (18-21° C).
Efficient protocolos for in vitro propagation (plant cloning) were established for a long list
of  medicinal  plants  like  Panax  ginseng  [79,  80],  Aloe  vera  [81],  Angelica  sinensis,  Gentiana
davidii [82], Chlorophytum borivilianum [83, - 86), Tylophora indica [87, 88], Catharanthus roseus
[89], Holostemma ada-kodien and Ipomoea mauritiana [90], Saussurea involucrata [91], Kniphofia
leucocephala  [92],  Podophyllum  hexandrum  [93],  Saussurea  obvallata  [94],  Ceropegia  candela‐
brum  [95],  Syzygium alternifolium  [96], Chlorophytum arundinaceum  [97], Rotula aquatica  [98,
99], etc.
Establishment of micropropagation system is a base for conservation of the species and for
protection  of  the  genefund,  as  well  as  for  studies  of  valuable  substances  in  important
medicinal plants. Different strategies are developed as well for establishment of cell cultures
aiming at production of biologically active compounds. These systems could be used for
large scale cultivation of plant cells  for obtaining of secondary metabolites.  These meth‐
ods are reliable and give possibility for continuous supply of raw materials for produc‐
tion of natural products [45, 82].
Environmental Biotechnology - New Approaches and Prospective Applications242
8. In vitro cultures and application of biotechnology in Gentiana,
Leucojum and Rhodiola
In this chapter a small part of the successful in vitro research in medicinal plants and the
application of “green biotechnology” methods for protection of endangered species will be
illustrated by examples from the investigations in the genera of Gentiana, Leucojum and
Rhodiola. These groups of medicinal plants were chosen because the three of them are with
outstanding importance for the pharmaceutical and nutraceutical industries. The species
belonging to them are worshiped for their multiple beneficial health effects and have been
used for thousands of years in folk medicine all over the world. However, their distribution is
at different parts of the Earth – Gentians are the most widely spread in various climatic zones,
Rhodiola covers less territory, predominantly in the cold regions in north and high mountains,
while Leucojum can be found in limited warm and south regions in Europe. Many species from
Gentiana, Rhodiola and Leucojum genera can be found in Bulgaria but most of them are endan‐
gered and included in the Red Book like Gentiana lutea, Rhodiola rosea and Leucojum aestivum.
In world scale level of protection – Leucojum spp are in the list of the most threatend with heavy
measures of restriction. Nearly all Gentiana species are endangered while many Rhodiola
species are under special regime of use. However, one and the same Rhodiola species may be
close to extinction in one country but widely spread (even as a weed) in another country.
Another consideration of ours is the ability of the plants from these genera to be cultivated in
field what was possible for Gentiana, partially for Rhodiola and not possible for Leucojum.
Described here examples illustrate different levels of development of in vitro cultures and
application of biotechnology to the three chosen groups of herbs. Development of in vitro
cultures started about 40 years ago in Gentiana, 25 years ago in Rhodiola and 20 years ago in
Leucojum.
The most intensive in vitro research was carried in Gentiana obtaining all kinds of in vitro
cultures, including somatic embryo cultures, with success in cryopreservation, in biotrans‐
formation and genetic metabolic engineering. Rhodiola occupies a middle position with con‐
siderable success in callus, suspension and micropropagation systems. Cultivation in
bioreactors, biotransformation and genetic transformation were successful.
Leucojum seems to be the most difficult, though protocols for clonal propagation have been
established and gene bank in vitro has been reported (in Bulgaria). Callus, suspension and
organogenic cultures could be obtained and growth in bioreactors with possibilities for
biotransformation and even genetic transformation (though at this stage without synthesis of
galanthamine).
Bulgaria is a pioneer in Leucojum aestivum biotechnology. It is in the frontiers of micropropa‐
gation of Rhodiola rosea and has less investigation in Gentiana in vitro cultures.
Genus Gentiana belongs to family Gentianaceae and is a group of medicinal plants of special
interest. It is a large genus comprising of about 400 species widely distributed in the mountain
areas of temperate zones [100], including Central and South Europe. Most of the species are
interesting to horticulture for their beautiful and attractive flowers but they have more
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important medicinal value, which is due to the production of secondary metabolites in their
roots (Radix Gentianae). The most efficient ones are the bitter secoiridoid glucosides (gentio‐
picroside, amarogentin), xanthones, di- and trisacharides, pyridine alkaloids [66, 101].
Traditionally, the pharmaceutical industry largely depends on wild sources exploiting
intensively the natural areals. The annual drug demands have been much higher than the
production from wild sources [66]. At the same time many gentians are either difficult to grow
outside their wild habitat or their cultivation (if possible) proved to be not economic. Contin‐
uous collection of plant material from natural habitats has led to the depletion of Gentiana
population and many representatives of the genus are protected by law. Some of the gentians
having the status of endangered species, for example, are: Gentiana lutea L. - included in the
Red Book of Bulgaria and of other European and world countries [66]; Gentiana kurroo Royle
- close to extinction and legally protected by law [102]; Gentiana dinarica Beck - a rare and
endangered species of the Balkan Dinaric Alps; Gentiana asclepiadea L. - distributed in South
and Central Europe, Gentiana triflora, Gentiana punctata, Gentiana pneumonanthea - under
protection of its progressively decreasing habitats; Gentiana dahurica Fisch – with exhausted
natural resources though this species could be cultivated in some areas of the northwest of
China; Gentiana straminea Maxim an endangered medicinal plant in the Qinghai-Tibet Plateau
[103]. Due to problems with germination of seeds in in vivo conditions as well as the high
variability of generatively propagated plants these species have attracted the attention of
scientists being aware of the potential of biotechnology. The genetic variability of endemic or
endangered species is usually very low and methods (like in vitro micropropagation) of
conservation and restoration of natural resources have been given much attention in the last
years. Despite the remarkable success of the tedious and wide investigations worldwide in
vitro cultures of Gentiana species proved to be very difficult to achieve because of their low
natural capacity of regeneration which was manifested in the multiplication in vitro, too [104].
First investigations on establishment of in vitro cultures of Gentiana were reported a quarter of
century ago. Wesolowska et al. [105] succeeded in induction of callogenesis in G. punctata and
G. panonica and of organogenesis and rhizogenesis in G. cruciata and G. purpurea. Authors
observed that regenerated plants synthesize secoiridoids, which could not be found in the wild
plants. This raised the hopes for the application of biotechnology techniques to other species
of the Gentiana genus. The next decade the scientists explored the basic factors and plant
requirements for establishment of in vitro cultures and micropropagation in various gentians.
Different explants were tested for development of efficient regeneration schemes.
Using shoots and node fragments as explants, regeneration systems of Gentiana scabra var
buergeri [106], Gentiana kurroo [107], Gentiana cerina, Gentiana corymbifera [65], Gentiana puncta‐
ta [108], Gentiana triflora [109, 110] and Gentiana ligularia [111] were established. Stem segments
with meristem tissue were appropriate explants to initiate tissue cultures and to induce
formation of shoots de novo in four other species of Gentiana: G. lutea G. cruciata, G. acaulus and
G. purpurea [66]. Different explants (shoot tips, lateral green buds, and root segments) were
tested in Gentiana lutea [112]. Leaf explants were used as well to induce shoots of Gentiana
macrophylla [113] and G. kurroo Royle [107, 114]. Vinterhalter et al. [115] micropropagated
Gentiana dinarica Beck using axillary buds as explants.
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Seeds in different stage of maturity were object of quite strong interest as an initial plant
material for in vitro cultures. Considerably high germination of 54 % was achieved when seeds
of G. corymbifera were cultured on a Murashige and Skoog (MS) medium containing 100 mg/l
gibberellic acid (GA3) for 70 days. In the absence of GA3 germination did not exceed 5% [65].
Immature seeds in different stages of ripening were tested in order to find out the most suitable
initial material to obtain in vitro cultures and multiplication of Gentiana lutea. Despite the
addition of 0.5 mg/l of gibberellic acid to the MS medium, the average germination was quite
low 21% [112]. Seedlings from immature and mature seeds of Gentiana pneumonanthe and
Gentiana punctata were also chosen as initial material to excise shoot tips and one-nodal cuttings
for induction of organogenesis and further clonal propagation [104, 116]. Petrova et al. [40]
studied the possibility for micropropagation of Bulgarian ecotype of Gentiana lutea using stem
segments with two leaves and apical or axillary buds excised from mature seeds germinated
in vitro (Figure 1). To increase the germination seeds were treated with 0.03% GA3 for 24 hours.
Some of the seeds were mechanically scarified in the micropile region. Germination was
initiated on three variants of nutrient media based on MS and different concentration from 25
to 100 mg/l of GA3. In these investigations, GA3 and scarification stimulate G. lutea seed
germination. Only 20 % of the non-scarified and 33.33 % of the scarified seeds germinated on
the control medium. Giberrellic acid in concentration of 50 mg/l proved to have optimum effect
resulting in 42.5 % germination for the nonscarified seeds and 60 % for the scarified ones.
Lower and higher levels of GA3 stimulated in a less extend the seed germination but the
response to GA3 of the scarified seeds was stronger than that of the non-scarified ones.
In vitro response is determined, as mentioned before, not only by the explant type but by
the  media  composition as  well  and by the  effect  of  the  plant  growth regulators  on the
dedifferentiation  and  redifferentiation  processes  undergoing  in  the  explants  cultured  in
vitro.  Many reports,  especially at the beginning of the in vitro  investigations of gentians,
pointed out that the cytokinine benzyl aminopurine BAP (or benzyl adenine BA) and the
auxines  indolacetic  acid  (IAA)  or  naphtilacetic  acid  (NAA)  were  the  best  plant  growth
regulators  for  induction  of  organogenesis  and  regeneration  of  plants  which  allowed
establishment of  a  micropropagation schemes.  Among the numerous examples,  some of
them were mentioned below as an illustration.
The initial results of Sharma et al. [107] were very promising reporting fifteen-fold shoot
multiplication of Gentiana kurroo, which was obtained every 6 weeks on Murashige and Skoog's
medium (MS) containing 8.9 μM benzyladenine and 1.1 μM 1-naphthaleneacetic acid. The
efficiency of these plant growth regulators were confirmed in the experiments with other
species. Optimal shoot multiplication of G. dinarica was achieved on MS medium enriched
with 1.0 mg/l BA and 0.1 mg/l NAA [115]. The ideal medium for adventitious buds formation
and for differentiation of calli contained 0.6 mg/l BA and 0.1 mg/l NAA [117] while the ideal
medium for induction of calli from tender stems of Gentiana scabra was by substitution of NAA
with 2,4 D in concentrations of 1.0-1.5 mg/l at the background of the same cytokinin –BA at
lower concentration of 0.2 mg/l.
Momcilovic еt al. [66] observed that the optimal concentrations of the two plant hormones BAP
and IAA were slightly different in the four investigated species Gentiana acaulis L., G. crucia‐
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ta L., G. lutea L. and G. purpurea after different combinations of concentrations were tested (1.14
μM IAA with BA in various concentrations of 1.11-17.75 μM, or 8.88 μM BA with various IAA
concentrations 0.57-9.13 μM). Excised nodal segments of axenically germinated seedlings were
initially transferred to MS, supplemented with 8.88 μM BA and 1.14 μM IAA. Axillary buds
started to grow on all node segments within a few days. Their stems remained short (5 to 15
mm for G. acaulis and G. cruciata, respectively) though the leaves reached a length between 25
mm (G. acaulis) and 120 mm (G. cruciata). Since only the shoots of 5-10 mm were chosen for
subculturing, a four to six-fold multiplication was achieved every 4 weeks. Production of well-
developed shoots was stimulated by increasing BA concentrations in the presence of 1.14 μM
IAA. Indoleacetic acid concentrations higher than 2.28 μM suppressed shoot size in all
investigated species. Similar observations were made by Zeleznik et al. [112] who induced
shoots proliferation from Gentiana lutea shoot tips on MS medium supplemented with 1 mg/l
of indoleacetic acid (IAA) and 0.1 mg/l benzyladenin (BA) which caused proliferation in one
third of the cultured shoots in a period of 21 days.
The experiments went further in investigating the effect of more plant growth regulators.
Based on the well known Murashige and Skoog nutrient medium and commonly used BAP
and IAA a comparison was made with other cytokinins and auxins.
Figure 1. Seed germination of G. lutea on MG2 medium (MS basal medium enriched with 50 mg/l GA3) [40].
Bach and Pawlowska [116] studied the efficacy of four cytokinins (BA, kinetin, thidiazuron, 2-
iP) and gibberellin at the concentration of 1.5 μM for propagation of Gentiana pneumonanthe.
The highest multiplication rate was achieved in the culture of the one-nodal cuttings on
medium supplemented with 10.0 μM BA. In other experiments [104] media supplemented
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with 2-iP or zeatin and IBA ensured a low multiplication of Gentiana punctata. Clonal propa‐
gation was slightly improved by addition of maize extract to the culture media.
Different concentrations and combinations of BAP (1 – 2 mg/l), zeatin (1 – 2 mg/l), IAA (0.1 –
0.2 mg/l), 2-iP (0.5 mg/l), and 2,4-D (0.5 mg/l) were used for bud induction and shoot multi‐
plication of Gentiana lutea [40]. Best results were recorded on MP1 nutrient medium supple‐
mented with 2 mg/l zeatin and 0.2 mg/ IAA. The mean shoot number per explant was relatively
high reaching 4.57 and the average shoot height - 3.90 cm. Second in efficiency was MP3
nutrient medium supplemented with 2 mg/l BA and 0.2 mg/l IAA inducing 4.00 shoots on
average per explant (Figure 2).
In vitro response may be influenced by other characteristics of the culture media like medium
consistence. Sadiye Hayta et al [118] observed that efficient production of multiple shoots of
G. cruciata L. directly from nodal segments, inducing 3.9 shoots per explants on average was
Figure 2. In vitro micropropagation of Gentiana lutea L. on MPl medium (MS basal medium enriched with 2 mg/l zea‐
tin and 0.2 mg/l IAA) (The mean number of shoots per explant reaching 9 in Vth passage.) [40].
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stimulated on a semi-solidified Murashige and Skoog (MS) basic medium enriched with 2.22
μM 6-benzyladenine (BA), 2.46 μM indole-3-butyric acid (IBA) [118].
In gentiana’s experiments plant growth regulators were investigated not only as a factor for
establishment of in vitro cultures but as a factor which may effect biosynthesis of the biologi‐
cally active substances in the regenerated plantlets or shoots induced in vitro.
Similar observation about the influence of the plant growth regulators on the synthesis of
secoiridoids, flavonoids and xantones was studied by Mencovic et al. [119]. There was
tendency for a negative correlation between the levels of biologically active substances
produced by the regenerants and the concentration of BAP and IAA added into the culture
media.
Dević et al. [120] were interested in the effect of applied phytohormones on content of
mangiferin in Gentiana asclepiadea L. in vitro cultures. The content of mangiferin in different
plant material was determined by High Performance Liquid Chromatography (HPLC)
analysis revealed that the content of mangiferin in the shoots obtained in vitro varied with
different concentration of applied cytokinine and different auxins. There was no detectable
content of mangiferin in roots obtained in vitro [120].
Rooting is the next crucial step after successful regeneration and multiplication of plants.
Rooting was accomplished successfully in excised Gentiana kurroo shoots grown on MS basal
medium containing 6% sucrose [107]. Pawlowska and Bach [116] observed too that in vitro
multiplied shoots of Gentiana pneumonanthe formed roots on a medium without growth
regulators. However, the auxins IAA, NAA, and IBA at a concentration of 0.5 μM and 1 μM
stimulated rhizogenesis in excised axillary shoots with IAA demonstrating the best effect.
Relatively high percentage of 52 % formation of roots from multiplied shoots of Gentiana
lutea was achieved on MS medium supplemented with 2 mg/l of naphtalenacetic acid (NAA)
[112]. Better results were reported by Petrova et al. [40] for Gentiana lutea when shoots were
transferred to half strength MS medium enriched with either IAA (1 or 2 mg/l), IBA (2 or 3 mg/
l) or NAA (0.5 or 3 mg/l). The best results of 92% and 91% rooting were obtained on half strength
MS nutrient media containing 3 mg/l IBA or 3 mg/l NAA, respectively. Mean root length was
almost equal in the both cases varying from 1.48 cm to 1.95 cm. Spontaneous rooting on plant
Gentiana dinarica growth regulator-free medium occurred in some 30 % of shoot explants.
Rooting was stimulated mostly by decreased mineral salt nutrition and a medium with half
strength MS salts, 2% sucrose and 0.5–1.0 mg/l IBA was considered to be optimal for rooting.
Wen Wei and Yang Ji [117] confirmed that the ideal medium for the rooting culture and rooting
sub-culture of G. scabra tube seedling was 1/2 MS with 0.1 mg/l IAA and 0.3 mg/l NAA. The
highest rooting of 81.7% of G. cruciata regenerants was also observed on half-strength MS
medium supplemented with 2.46 μM IBA [118]. Beside the successful combinations of plant
growth regulators inducing rooting there were reports on less favorable culture media. Butiuc-
Keul et al. [104] report about failure in rhizogenesis induction in Gentiana punctata shoots
transferred on medium supplemented with 1.0 mg/l each NAA and 2iP [104].
Acclimatization and adaptation efficiency varied with the species. In the early experiments,
Pawlowska and Bach [116] achieved 65 % survival of rooted plantlets of Gentiana pneumo‐
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nanthe after being potted in soil in a greenhouse. Further, the plants were successfully planted
outdoors in field conditions. These in vitro regenerants had a greater number of flowers and stems
than plants grown in a natural habitat. In vitro plantlets of Gentiana punctata have been transfer‐
red to soil after six weeks of culture and acclimatization was successfully obtained, too [104].
Peat-based substrate for rooting plantlets of Gentiana dinarica was successfully used, too [115].
Turf/vermiculite mixtures were very appropriate for acclimatization of plants with well-
developed roots transferred to pots in growth chambers. All the acclimatized plants (100%)
survived, remained healthy and analysis of the content of secondary metabolites in the clones
was determined by HPLC. The presence of gentiopicroside, loganic acid, swertiamarin, and
sweroside in the samples was confirmed. Gentiopicroside was found to be the major com‐
pound [118].
For the purposes of conservation of the endangered species and for restoration of their habitats
it is of a great importance to maintain the genetic stability of the regenerated plants in vitro. In
this aspect the investigations of Kaur R et al [121] are very interesting. Genetic stability of
Gentiana kurroo micropropagated plants maintained in vitro for more than 10 years was studied
using randomly amplified polymorphic DNA (RAPD) and karyotype analysis. A large number
of micropropagated plantlets developed from nodal segment explants were assessed for
genetic variations and compared with donor mother plant maintained in the arboretum. Out
of 20 RAPD primers, 5 displayed the same banding profile within all the micropropagated
plants and donor mother plant. No chromosomal variations were observed by the karyotype
analysis. High multiplication rate of healthy plant material associated with molecular and
karyotypic stability ensures the efficacy of the protocol to be used across a long period for in
vitro propagation of this important medicinal plant species. These results are extremely
important for the application of biotechnological methods and especially of micropropagation
for the multiplication of the species for their conservation when in vitro clones should be
identical to the donor mother plants from the natural habitats.
Somatic embryogenesis is another morphogenetic pathway for regeneration of plants, which
is considered the most efficient way to regenerate plants [122]. In contrast to organogenesis
when the buds and shoots are not formed obligatory from one cell, a somatic embryo derives
from a single cell. This way of development assures greater genetic stability and identity with
the initial plant. It opened new possibilities for large-scale multiplication of valuable plants
with many expectations for mass production of artificial seeds.
However, somatic embryogenesis is more difficult to obtain. Nevertheless, it was successfully
induced in a number of Gentiana species: Gentiana lutea [122, 123], Gentiana crassicaulis, Gentiana
cruciata [123, 124], Gentiana pannonica [123], Gentiana tibetica [123], Gentiana pneumonanthe and
G. kurroo Royle [116, 123, 125, 126, 127], Gentiana davidii var. formosana (Hayata) [128], Gentiana
straminea [103, 129].
Like in the previously described experiments for micropropagation, one of the requirements
leading to success is the appropriate choice of explants. The most commonly used explants
were: leaves from the first and second whorls, the apical dome, and axenic shoot culture used
for Gentiana kurroo (Royle), Gentiana cruciata (L.), Gentiana tibetica (King. ex Hook. f.), Gentiana
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lutea (L.), and Gentiana pannonica (Scop.) [123]; stem explants for initiation of callus and cell
suspension cultures of G. davidii var. formosana [128]; hypocotyl (adjacent to cotyledons) of 10
days old seedlings of Gentiana cruciata [124]; seedling explants (root, hypocotyl and cotyledons)
for Gentiana kurroo (Royle) embryogenic callus [125]; immature seeds (claimed to be superior
initial material) of Gentiana straminea Maxim [129].
Plant growth regulators are the other very important factor for triggering the totipotence of
the plant cell to develop somatic embryo. Unlike organogenesis and shoot formation in
gentians where among the numerous tested plant growth regulators several cytokinines and
auxins could be distinguished as more prominent, in the case with somatic embryogenesis it
was difficult to point out the best ones. In a large number of combinations a wide spectrum of
natural phytohormones and synthetic phytoregulators were examined: auxins like α-naph‐
thaleneacetic acid (NAA), 2,4-dichlorophenoxyacetic acid (2,4-D), 3,6-dichloro-o-anisic acid
(dicamba), and cytokinins: zeatin, 6-furfurylamonopurine (kinetin), N-phenyl-N′-1,2,3-
thiadiazol-5-ylurea (TDZ), N-(2-chloro-4-pyridyl)N′-phenylurea, 6-benzylaminopurine
(BAP) or benzyladenine (BA), and adenine sulfate. However, the natural auxin indoleacetic
acid is not seen in this list. It makes impression that more auxins of synthetic origin are involved
in the studies.
The role of the plant growth regulators will be illustrated by several examples of establish‐
ment of cell suspension cultures and somatic embryogenesis. One of the pioneer investiga‐
tions was performed by Fu-Shin Chuen et al. [128]. Fast-growing suspension cell cultures
of  G.  davidii  var.  formosana  were established by subculturing callus,  which was initiated
from stem explants on MS basal medium supplemented with 0.2 mg/l kinetin and 1.0 mg/
l NAA. Cell suspension growth was maintained in liquid MS basal medium supplement‐
ed with 0.2 mg/l kinetin and 3% sucrose. The cultures were incubated on an orbital shaker
(80-100 rev/min) at 25 ± 1°C and low light intensity (2.33 μEm-2s-1). The low pH of 4.2-5.2
was crucial for the successful cell division and growth.
Quite interesting work from the early period of somatic embryogenesis was that one of Mikula
et al., [124]. Authors investigated the effect of phytoregulators on Gentiana cruciata structure
and ultrastructure changes occurring during tissue culture. MS induction medium containing
1.0 mg/l dicamba, 0.1 mg/l NAA, 2.0 mg/l BAP and 80 mg/l adenine sulfate was used for
culturing of hypocotyl (adjacent to cotyledons) explants from 10 days old seedlings. During
the first 2 days of culture cell division of epidermis and primary cortex was the first response.
Numerous disturbances of karyo- and cytokinesis were observed, leading to formation of
multinuclear cells. With time, the divisions ceased, and cortex cells underwent strong expan‐
sion, vacuolization and degradation. About the 6th day of culture, callus tissue was formed and
the initial normal divisions of vascular cylinder cells were observed. Cells originating from
that tissue were small, weakly vacuolated, with dense cytoplasm containing active-looking
cell organelles and actively dividing leading to formation of embryogenic callus tissue. During
the 6–8th week of culture, in the proximal end of the explant, masses of somatic embryos were
formed from outer parts of intensively proliferating tissue. Production of somatic embryos
was more effective from suspension culture than from agar medium. Liquid culture made it
possible to maintain the cell suspension’s embryogenic competence for 5 years.
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Quite vast and extensive studies on the establishment of gentians embryogenic cultures and
their biotechnological potentials were carried by a research group with impressive publishing
activity [114, 126, 130, 131]. Culture initiation and intensive callus proliferation of Gentiana
cruciata were stimulated by 2,4-D and kinetin using various explants [130]. However, only
some of the tissues of initial explant were able to form embryogenic callus. Cytological,
ultrastructural and scanning analysis brought evidences that almost each of the cotyledon cells
responded by callus formation and somatic embryo differentiation. Central cylinder of the
hypocotyls gave the best response for embryogenic proliferation compared to other tissues of
hypocotyls. Another medium containing 1.0 mg/l dicamba, 0.1 mg/l NAA, 2.0 mg/l BAP and
80 mg/l SA proved to be very efficient to maintain very long-term cell suspension cultures of
proembryogenic masses. Long-term culture provided opportunities for numerous analysis to
have evidences of the single cell origin of somatic embryos which originated from freely
suspend single cells or single cells from the embryogenic clusters. Medium supplemented with
GA3 helped to complete development and stimulated the somatic embryo conversion in
germlings. Embryogenic potential was genotype dependent with G. tibetica and G. kurroo being
outstanding generating more than hundreds somatic embryos from 100 mg of tissue for more
than two years. Interestingly the regeneration ability was maintained not only in the long-term
suspension cultures but it was demonstrated in the protoplast cultures, too [126].
Protoplasts  with  very  high  viability  ranging  from  88  to  96  %  were  isolated  from  cell
suspensions derived from cotyledon and hypocotyl of Gentiana kurroo [126]. Three techni‐
ques  of  culture  and six  media  were  evaluated in  terms of  their  efficiency in  producing
viable cultures and regenerating entire plants. The best results of plating efficiency (68.7%
and 58.1% for cotyledon and hypocotyl derived suspensions, respectively) were obtained
with  agarose  bead  cultures  in  medium containing  0.5  mg/l  2,4-D  and  1.0  mg/l  kinetin.
Regeneration of plants was also possible when embryos were transferred to half-strength
MS medium. However,  flow cytometry analysis  revealed increased amounts of  DNA in
about one third of the regenerants which limits the application of isolated protoplasts in
the  programs  for  conservation  and  reproduction  of  an  endangered  species.  Hence,  the
efforts  were directed again to cell  and tissue cultures examining the factors for efficient
and reliable plant regeneration, even to examining photosynthetic activity in dependence
of the sucrose content in the emryogenic culture media [126].
Fiuk and Rybczyn´ski [123, 125] expanded their studies using leaves derived from axenic shoot
culture of five Gentiana species (Gentiana kurroo, Gentiana cruciata, Gentiana tibetica, Gentiana
lutea, and Gentiana pannonica) and cultured on MS basal medium supplemented with three
different auxins: 2,4-D, NAA, or dicamba in three concentrations of 0.5, 1.0, or 2.0 mg/l; and
five different cytokinins: zeatin, kinetin, BAP, TDZ, and N-(2-chloro-4-pyridyl)N′-phenylurea
in concentrations between 0.25 and 3.0 mg/l depending on the cytokinin activity. After two
months the percentage of embryogenesis was the highest for G. kurroo reaching 54.7% and
depending on plant growth regulators. This gentian was the only species responding to the
all tested combinations of auxins and cytokinins, while none of the 189 induction media
stimulated somatic embryogenesis from G. lutea explants. Efficiency of embryogenesis was
genotype dependent G. tibetica and G. cruciata both produced an average of 6.6 somatic
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embryos per explant, while G. pannonica and G. kurroo regenerated at 15.7 and 14.2 somatic
embryos per explant, respectively. Optimum regeneration was achieved in the presence of
NAA combined with BAP or TDZ. NAA also stimulated abundant rhizogenesis. Somatic
embryos were also regenerated from adventitious roots of G. kurroo, G. cruciata, and G.
pannonica. Somatic embryos developed easily into plantlets on half strength MS medium.
The same research group extended its investigations on the factors influencing efficiency of
somatic embryogenesis in cell suspension of Gentiana kurroo (Royle) - the species revealing the
best morphogenic potential in their previous studies [125]. Suspension cultures were initiated
in liquid MS medium supplemented with 0.5 mg/l 2,4-D and 1.0 mg/l kinetin from embryogenic
callus derived from seedling roots, hypocotyls and cotyledons. Unexpectedly the highest
growth rate was observed for root derived cell suspensions. Further more differences in
aggregate structure depending on their size were detected by microscopic analysis. In order
to assess the embryogenic capability of the particular culture, 100 mg of cell aggregates were
implanted on MS agar medium supplemented with 0–2 mg/l kinetin, 0–2 mg l/l GA3 and 80
mg/l adenine sulfate. The highest number of somatic embryos was obtained for cotyledon-
derived cell suspension on GA3-free medium, but the presence of the other plant growth
regulators (0.5–1.0 mg/l kinetin, 0.5 mg/l GA3 and 80 mg/l adenine sulfate) determined the best
morphological quality of embryos. The morphogenic competence of cultures also depended
on the size of the aggregate fraction and was lower when size of aggregates decreased. Flow
cytometry analysis revealed 100% uniformity for regenerants derived from cotyledon suspen‐
sion but lack of uniformity of plantlets obtained from hypocotyls suspension. These observa‐
tions were of great significance for the choice of appropriate explants and culture media
conditions for the multiplication of a particular gentian species via somatic embryogenesis.
Cai YunFei et al. [129] confirmed the role of the explant and its interaction with the plant growth
regulators added into the media of Gentiana straminea Maxim. They observed that calli induced
from immature seeds were superior to those from hypocotyls or young leaves in regeneration
via somatic embryogenesis and demonstrated that 2,4-D was efficient for both callus induction
and embryogenesis, IAA is suitable for embryogenic callus proliferation, and BAP promotes
both embryo development and the accumulation of gentiopicroside in the cultures. Experi‐
ments went further in exploring Gentiana in vitro cultures potentials by selecting regenerated
plants for high gentiopicroside content. A highly productive clone was selected. Its cells
contained 5.82 % of gentiopicroside, which levels were two folds higher than the control plants
(1.20-3.73 %). Genetic stability of the regenerated plants was also proved both by cytological
and random amplified polymorphic DNA analyses.
Similar experiments were performed with Gentiana straminea Maxim. MS medium supple‐
mented with 2 mg/l 2,4-D and 0.5 mg/l BA was the best medium for embryogenic callus
induction from leaf explants [103]. Genetic stability of the regenerants was assessed by 25 inter
simple sequence repeat (ISSR) markers. Out of 25 ISSR markers, 14 produced clear, reprodu‐
cible bands with a mean of 6.9 bands per marker confirming that the regenerants maintained
high genetic fidelity.
One of the recent reports [122] presented interesting results for the possibility to use recurrent
somatic embryogenesis in long-term cultures of Gentiana lutea for production of synthetic
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seeds. After induction of somatic embryogenesis in the presence of auxins in the first cycle of
in vitro cultures, recurrent somatic embryogenesis was performed in long-term cultures in the
absence of phytohormones but in the presence of the sugar alcohols mannitol and sorbitol.
Adventive somatic embryos were generated continuously at a high rate along with maturation,
germination and development into plants.
One of the possibilities of biotechnology for conservation of rare species is the establishment
of in vitro germplasm banks, which may include cryopreservation of in vitro multiplied
valuable plant material. There are several interesting publications of one research group
dedicated to this problem [124].
For preservation of proembryogenic masses of G. cruciata, four protocols of cryopreservation
were studied: direct cooling, sorbitol/DMSO treatment, vitrification, and encapsulation. Direct
cooling and sorbitol/DMSO treatment was unsuccessful. Vitrified tissue required a minimum
3 weeks culture on solid medium for cell proliferation to reach the proper fresh weight for
manipulation. Alginate beads with PEMs were transferred directly to liquid medium for post-
freezing culture. Vitrification and encapsulation maintained high viability of post-freezing
proembryogenic masses, but encapsulation ensured faster restoration of G. cruciata cell
suspension [124]. A reliable technique for cryopreservation by encapsulation was developed
for two suspension cultures of Gentiana species (Gentiana tibetica and G. cruciata) of different
ages and embryogenic potential. A water content of 24-30% (fresh weight basis) after 5-6 h
dehydration of encapsulated cells of gentians yielded the highest survival (68% for G. tibetica
and 83% for G. cruciata) after cryopreservation. Flow cytometry showed that cryopreservation
did not change the genome size neither of the somatic embryos nor of the regenerants [132].
The embryogenic cell suspension culture of Gentiana cruciata, cryopreserved by the encapsu‐
lation/dehydration method, survived both short- (48 h) and long-term (1.5 years) cryostorage
with more than 80% viability. The (epi)genetic stability of 288 regenerants derived from: non-
cryotreated, short-term, and long-term cryo-stored tissue was studied using metAFLP markers
and ten primer combinations. AFLP alterations were observed but they were not associated
with the use of cryopreservation, but were probably related to the in vitro culture processes
[133]. These results gave great hopes for the use of cryo-techniques in preservation of valuable
medicinal species.
Genetic transformation was also applied to gentiana species aiming at obtaining higher
production of biologically active substances or biosynthesis of new valuable compounds.
Agrobacterium rhizogenes mediated transformation was achieved in shoots of micropropagated
Gentiana acaulis, G. cruciata, G. lutea, and G. purpurea inoculated with suspensions of Agrobac‐
terium rhizogenes cells [134, 135]. Few years later Menkovic et al [119] after infection with
Agrobacterium rhizogenes managed to obtain nine hairy root clones which differed in the amount
of secondary metabolites. Agrobacterium tumefaciens was also used for inoculation of Gentiana
punctata [136] and Gentiana dahurica Fisch by A. tumefaciens [137]. However, due to the great
opposition in many countries against the genetically modified organisms, especially these ones
with potential use in food and nutraceutical industries genetic transformation experiments
remained more in the laboratory mainly to study the metabolic pathways.
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Genus Leucojum.Leucojum aestivum (summer snowflake) is one of the most worshiped
medicinal plants on the Balkan region and in the world. Leucojum aestivum L. (Amaryllidaceae
family) is a polycarpic geophyte distributed in the wetlands of Central and South Europe
(Mediterranean and the Balkans) and in West Asia. L. aestivum grows on alluvial soils with
high nitrogen levels. The mean size of the plants increased with the water content of the soil.
Seed reproduction is whimsical. Seed set of the plants was not influenced by the size of a
population, but strongly increased with the density of flowering plants. Optimal temperature
for seed germination is 20-25oC [138]. Overharvesting of its bulbs for medical purposes has
brought to a destruction or alteration of its habitats across Europe [138]. Therefore, summer
snowflake has turned into an endangered species and is protected in several European
countries (e.g. Bulgaria, Hungary and Ukraine).
Leucojum aestivum L. is used as a source of galanthamine - an isoquinoline alkaloid produced
exclusively by plants of the family Amaryllidaceae (mainly belonging to the genus Galanthus,
Leucojum and Narcissus). Due to its acetylcholinesterase inhibitory activity, galanthamine is
used for various medical preparations for the treatment of neurological disorders and
especially for senile dementia (Alzheimer’s disease) and infantile paralysis (poliomyelitis). A
very effective Bulgarian remedy to cure poliomyelitis was produced from L. aestuvum in the
middle of the XXth century. This marked tremendous interest and respect of the plant and
enormous demands for raw material. Despite the possibility for organic synthesis, galantha‐
mine is still extracted from natural sources. For industrial purposes L. aestivum plants are
harvested from wild populations in their natural habitats which causes increasing problems
regarding quality of the plant material as well as natural populations depletion. The limited
availability of the plants and the increasing demands for this valuable metabolite has imposed
urgent search for alternative approaches both for protection of the species and for production
of galanthamine. In this respect biotechnology methods could be used for in vitro storage of
genotype accessions from different natural populations with proven alkaloid profiles, for rapid
propagation of this threatened medicinal plant for both industry and natural resource
protection, and for production of its valuable biologically active substances under controlled
conditions. However, not so much data are available in the literature concerning in vitro
cultures of this plant.
The Bulgarian scientists Stanilova et al. [38] and Zagorska et al [139] are pioneer in establish‐
ment of in vitro cultures and micropropagataion of Leucojum aestivum. One of the prerequisites
for their success was the elaboration of a successful procedure for decontamination of the plant
material gathered from nature. Plant material should be used 42 days after collecting. The bulbs
were rinsed for 16 hours with stream water followed by immersion in 70% ethanol for 30 s and
sterilized with 0.1% HgCl2 for 3 min. Relatively good decontamination was achieved for leaf
explants applying hypochlorites – 47.46% using 5% Ca (ClO)2 for 6 min and 54.76% - 15%
NaClO for 20 min. During their initial studies of the morphogenetic potential of the basal and
apical parts of bulbs, stems, leaves and ovaries it was observed that the scales of L. aestivum
possessed the highest regenerative ability producing 4.08 - 4.19 regenerants per explant.
Whereas leaf explants had lower regeneration potential – 1.67 regenerants per explant.
Murashige and Skoog (MS) medium supplemented with 1 mg/l benzyladenine (BA) and 1 mg/
Environmental Biotechnology - New Approaches and Prospective Applications254
l kinetin as well as Linsmaier and Skoog (LS) medium enriched with 0.5 mg/l NAA and 0.1
mg/l kinetin proved to be the most suitable for direct organogenesis [38]. Rhyzogenesis was
induced on MS basal medium with reduced sugar content of 15 g/l and enriched with 0.1 mg/
l NAA, 0.1 mg/l kinetin and 0.1 mg/l BAP. Further investigations focused on in vitro clonal
propagation of L. aestivum. Twenty four clones were obtained and most of them demonstrated
high regeneration rates and stable alkaloid profiles. Galanthamine levels of some of the in
vitro obtained clones was as high as galantamine levels of commercially important represen‐
tative of Bulgarian L. aestivum populations. Five clones: four galanthamine-type and one
lycorine-type were selected as promising for further investigations [140].
In Turkey Karaogˇlu [141] confirmed the effectiveness of bulb-scales explants for micropropa‐
gation of Leucojum aestivum and tested immature embryos for initiation of in vitro cultures.
Using 2 and 4 bulb-scales explants the highest number of bulblets (6.67 and 5.83) were achieved
on MS medium containing 1 mg/l BA and 1 mg/l NAA or 2 mg/l BAP and 0.5 mg/l NAA,
respectively. Regeneration capacity of immature embryos was twice lower reaching 2.27
bulblets on MS medium containing 0.5 mg/l BA and 4 mg/l NAA. The best rooting of bulblets
regenerated from bulb scales was obtained on MS medium containing 1 mg/l NAA. Rooted
bulbs were finally transferred to compost and acclimatized to ambient conditions [141].
Later in vitro cultures of Leucojum aestivum were reported in Hungary. Kohut et al. [142]
succeeded to obtain from 81 % to 92 % contamination free material. Prior to surface sterilization
the old leaves and roots were dissected from the bulbs and they were stored at low temperature
of 2–3°C for 1 and 5 week periods. The bulbs, bulb scales and leaves of the bulbs were placed
on MS medium containing 1 mg/l BA and 0.1 mg/l NAA.
Shoot in vitro cultures were initiated also from bulb explants in others’ experiments [143].
However, Gamborg’s B5 medium was used for the initiation and maintaining of the cultures,
which were kept in darkness. This medium contained 30 g/l of sucrose, 1 mg/l 2,4-D, 0.5 g/l
casein hydrolysate, 2 mg/l adenine, and 10 mg/l glutathione. The in vitro cultures were
subcultured at 2.5 month intervals in MS medium supplemented with 1 g/l Ca(NO3)2, 0.5 mg/
l BAP, 0.01 mg/l IBA, and 2.93 mg/l paclobutrazol. During the subcultures, shoot-clumps which
were formed were cut to increase the number of explants, and the newly formed shoot clumps
were separated. The in vitro cultures were maintained at 23-25o C with a 16/8 h light /dark
photoperiod. Later the same research group [144] offered a three step protocol for in vitro long-
term conservation of L. aestivum which was used to create a genebank with accessions from 31
Bulgarian populations. For in vitro cultures dormant bulbs were used, which were cut into 8,
16 or more segments. For sterilization, these segments called “twin-scale” were treated with
70% ethanol for 30 s and sterilized with 1% HgCl2 for 3 min. The development of the shoot-
clumps started from the basal parts of the scales at the end of the first week. The development
of in vitro shoot-clump cultures was tested on three nutrient media: МS, B5, and QL with or
without plant growth regulators, BAP (0.5 - 3.0 mg/l), IBA (0.01 - 1 mg/l) NAA (0.2 - 2 mg/l)
and TDZ (1 - 2 mg/l), sucrose (0 - 120 g/l), and charcoal (2g/l). Shoot-clumps were obtained,
from explants cultivated on B5 medium (6), supplemented with 0.5 g casein hydrolyzate, 1
mg/l 2,4-D, 10 mg/l adenine, 10 mg/l glutathione, 30 g/l sucrose, 6 g/l agar. The fastest multi‐
plication however was observed on МS medium with 30 g/l sucrose, 2 mg/l BAP, 1.15 mg/l
Role of Biotechnology for Protection of Endangered Medicinal Plants
http://dx.doi.org/10.5772/55024
255
NAA. Increasing sucrose concentration up to 90 g/l resulted in higher mass of the obtained
bulbs. About 1000 regenerated bulbs with well-developed roots were successfully adapted at
ex vitro conditions. Authors observed that plant ex vitro adaptation depended on the bulb size.
The biggest bulbs (over 1.5 cm in size) were the most adapted (99 %) whereas about 60% of
the medium size bulbs (0.5-1.5 сm) and 20% of the small bulbs (less than 0.5 сm) survived.
Mainly easily rooting bulbs were formed on hormone free nutrient medium (МS with vitamins,
sucrose-30 g/l, charcoal - 2 g/l, and pH-5.6) [144].
Callus cultures from young fruits of Leucojum aestivum L. were obtained, too [145]. Non-
differentiated cell growth was stimulated by high concentrations of the auxin 2,4-D (4 mg/l)
and the cytokinin BA 2 mg/l. Callus tissue formed regenerants when 1.15 mg/l NAA and 2 mg/
l BA were added to the MS medium.
Somatic embryos were formed from callus tissues cultivated on MS medium containing 2
μМ or 5 μМ picloram (4-amino- 3,5,6-trichloropicolinic acid) and 0.5 μМ BAP [146]. Regener‐
ation of plants was possible on medium enriched with zeatin (0.5 μМ). Authors observed that
the processes of differentiated or non-differentiated growth leading to somatic embryogenesis
or callus growth, respectively, were influenced by ethylene or its precursor ACC (1-aminocy‐
clopropane-1-carboxylic acid). At higher concentrations (25 μМ) of picloram callus cultures
produced ethylene (9.5 nL/g fresh weight: F.W.) whereas no ethylene was detected in cultures
of somatic embryos cultivated on medium supplemented with 0.5 μМ NAA and 5 μМ zeatin.
Application of ACC increased ethylene production thus suppressing callus growth and
enhancing somatic embryos induction and globular embryos development. Another effect of
ACC was to induce galanthamine production in somatic embryo cultures (2% dry weight).
However, galanthamine production in callus cultures was induced by silver thiosulphate (STS)
though in low levels (0.1% dry weight). These results are promising for use of somatic embryos
cultures in bioreactors for production of galanthamine [146].
Alkaloid content in Leucojum aestivum  wild plants and their in vitro  cultures was studied
in a series of experiments carried out by a Bulgarian research group [143, 145, 147 - 150].
Callus  cultures  were  obtained  from  young  fruits  of  Leucojum  aestivum  on  MS  nutrient
medium supplemented with 4 mg/l 2,4 D and 2 mg/l BAP. Further, shoot cultures were
established by subculturing the obtained calli on the same nutrient medium supplement‐
ed with 1.15 mg/l NAA and 2.0 mg/l BAP. These in vitro systems were used to study the
growth  and  galanthamine  accumulation.  The  authors  observed  that  the  amount  of
accumulated galanthamine strongly depended on the level of tissues differentiation. The
maximum yield of biomass (17.8 g/l) and the maximum amount of accumulated galantha‐
mine (2.5 mg/l) were achieved under illumination after the 35th day of submerged cultiva‐
tion of one of the lines L. aestivum -80 shoot culture.
The  alkaloids  of  intact  plants,  calli  and  shoot-clump  cultures  of  L.  aestivum  were  ana‐
lyzed by capillary gas chromatography – mass spectrometry (CGC-MS).  In one series of
experiments fourteen alkaloids of  galanthamine,  lycorine and crinane types were identi‐
fied (11 in the intact plants and eight in the in vitro cultures) in alkaloid mixtures extract‐
ed from intact plants and in vitro cultures. Excellent peak resolution for the alkaloids was
exhibited and isomers of galanthamine and N-formylnorgalanthamine were well separat‐
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ed [147]. Applying the same methods of CGC-MS, extracts from bulbs collected from 18
Bulgarian  populations  and  from  shoot-clumps  obtained  in  vitro  from  eight  different
populations  were  subjected to  analysis  and nineteen alkaloids  were  detected.  Typically,
galanthamine type compounds dominated in the alkaloid fractions of L. aestivum bulbs but
lycorine, haemanthamine and homolycorine type alkaloids were also found as dominant
compounds in some of the samples. Galanthamine or lycorine as main alkaloids present‐
ed in the extracts from the shoot-clumps obtained in vitro. The galanthamine content ranged
from traces to 454 μg/g dry weights in the shoot-clumps while it was from 28 to 2104 μg/
g dry weight in the bulbs [143]. In other investigations twenty-four alkaloids were detected
analizing intact plants,  calli  and shoot-clump cultures. Shoot-clumps had similar profiles
to  those  of  the  intact  plant  while  calli  were  characterized with  sparse  alkaloid  profiles.
Seven shoot-clump clones produced galanthamine predominantly whereas another three
were dominated by lycorine. It was also observed that illumination stimulated accumula‐
tion of galanthamine (an average of 74 μg/g of dry weight) in shoot-clump strains while
in darkness galanthamine levels were two folds less (an average of 39 μg/g of dry weight).
The shoot-clumps, compared to intact plants, accumulated 5-folds less galanthamine. The
high variability  of  both  the  galanthamine content  (67% and 75% of  coefficient  of  varia‐
tion under light and darkness conditions, respectively) and alkaloid patterns indicated that
the shoot-clump cultures initiated from callus could be used as a tool for improvement of
the in vitro cultures production of the valuable substances [148]. The investigations extended
on the alkaloid patterns  in  L.  aestivum  shoot  culture  cultivated at  temporary immersion
conditions where 18 alkaloids were identified,  too.  The temperature of  cultivation influ‐
enced enzyme activities, catalyzing phenol oxidative coupling of 4'-O-methylnorbelladine
and formation  of  the  different  groups  Amaryllidaceae  alkaloids.  Decreasing  the  tempera‐
ture of cultivation of L. aestivum  80 shoot culture led to activation of para-ortho'  phenol
oxidative  coupling (formation of  galanthamine type  alkaloids)  and inhibited ortho-para'
and para-para' phenol oxidative coupling (formation of lycorine and haemanthamine types
alkaloids).  The  L.  aestivum  80  shoot  culture,  cultivated  at  temporary  immersion  condi‐
tions, was considered a prospective biological matrix for obtaining wide range of Amarylli‐
daceae alkaloids, showing valuable biological and pharmacological activities [150]. The most
recent report was about successful cultivation of shoot culture of summer snowflake in an
advanced  modified  glass-column  bioreactor  with  internal  sections  for  production  of
Amaryllidaceae  alkaloids.  The  highest  amounts  of  dry  biomass  (20.8  g/l)  and  galantha‐
mine (1.7 mg/l) were obtained when shoots were cultured at temperature of 22°C and 18
l/(l  h)  flow rate of  inlet  air.  At these conditions,  the L.  aestivum  shoot culture possessed
mixotrophic-type nutrition, synthesizing the highest amounts of chlorophyll (0.24 mg/g DW
(dry weight) chlorophyll A and 0.13 mg/g DW chlorophyll B). The alkaloids extract of shoot
biomass  showed  high  acetylcholinesterase  inhibitory  activity  (IC50  =  4.6  mg).  The  gas
chromatography–mass spectrometry (GC/MS) profiling of biosynthesized alkaloids revealed
that galanthamine and related compounds were presented in higher extracellular propor‐
tions while lycorine and hemanthamine-type compounds had higher intracellular propor‐
tions. The developed modified bubble-column bioreactor with internal sections provided
conditions ensuring the growth and galanthamine production by L. aestivum shoot culture
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[149]. The influence of the nutrient medium, weight of inoculum, and size of bioreactor on
both  growth  and  galanthamine  production  was  studied  in  different  bioreactor  systems
(shaking and nonshaking batch culture,  temporary immersion system, bubble bioreactor,
continuous and discontinuous gassing bioreactor) under different culture conditions. The
maximal  yield of  galanthamine (19.416 mg)  was achieved by cultivating the  L.  aestivum
shoots (10 g of fresh inoculum) in a temporary immersion system in a 1l bioreactor vessel
which was used as an airlift culture vessel, gassing 12 times per day (5 min) [151].
Completely different types of experiments were the attempts of genetic transformation with
Agrobacterium. Agrobacterium rhizogenes strain LBA 9402 has been tested [152] for its capacity
to induce hairy roots of this monocotyledonae plant. Diop et al. [152] have developed an
efficient transformation system for L. aestivum, which could be used to introduce genes
encoding enzymes of isoquinoline alkaloid biosynthesis into L. aestivum to enhance the
production of target molecules in this medicinal plant. However, the transformed roots
obtained did not synthesize galanthamine.
At this stage of in vitro research establishment of organogenic cultures and optimization of
galanthamine production by differentiated cells using the methods of biotransformation are
more promising and reliable.
Genus Rhodiola is highly varied among others in family Crassulaceae (comprising of 1500 species
in 35 genus). The genus Rhodiola includes over 200 quite polymorphic species, out of which 20
species (Rh. alterna, Rh. brevipetiolata, Rh. crenulata, Rh. kirilowii, Rh. quadrifida, Rh. sachalinensis,
Rh. Sacra etc.) have pharmacological properties and are used for production of medical
preparations [153].
Intensive and unscrupulous exploitation of the natural habitats in many countries has led to
extinction of these species in these regions [154]. This provoked nature-protecting measures
to be undertaken like (1) cultivation under appropriate conditions, (2) protection of the
populations in the protected areas, (3) including the species in Red Books of rare and endan‐
gered plants species. Rhodiola species contain various quantities of salidrosid – one of the most
important ingredients in the biological active complex [155 - 159]. Salidroside content in plants
varies depending on the genetical structure, the developmental stages, the plant age, the
ecological and agrobiological conditions [160] what is one of the reasons for the scientists to
look for conditions minimizing these effects by biotechnological way of more controlled
production of this biologically active compound. From another hand extracts from medicinal
plants are rich in other metabolites bringing to the multiple health benefits [159] what
stimulates search and identification of more biologically active substances which can be
produced in cultures in vitro.
In Bulgaria Rhodiola rosea (Golden root, Roose root) (Sedum roseum (L.) Scop., S. rhodiola DC.)
is under protection of the Act for biological diversity [161]. Rhodiola rosea is included in the Red
Books of Republic of Buryatia AR, of Yakut ASSR, of Mongolia; “Rare and Extinct Plant Species
in Tyva Republic,” “Rare and Extinct Plant Species in Siberia,” in Great Britain—Cheffings &
Farrell, in Finland—category “last concerned.”(according to IUCN Red List Categories and
Criteria: Version 3.1 (IUCN, 2001).
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Rhodiola rosea species are worshiped for their roots and rhizomes therapethical role in many
diseaases. Rhadix et Rhizoma Rhodiolae of Rh. rosea are used in medicine for optimization of own-
body biochemical and functional reserves of the organism, for stimulation of body’s nonspe‐
cific resistance for regulation of the metabolism, central nervous system, cardiovascular system
and the hormonal system [162 – 164] for rehabilitation after heavy diseases, for prophylactics
of onco disease [153, 159, 165], etc. Rhodiola quadrifida (Pall.) Fisch. et May is a perennial grassy
plant growing predominantly in some highland regions of the former USSR (Altai, Sayan), in
East Siberia, in some mountainous regions of China (Sichuan) and in high mountain regions
of Mongolia. It is used in traditional medicine of Mongolia and Tibet, against fatigue, stress,
infections, inflammatory diseases and protection of people against cardiopulmonary function
problems when moving to high altitude [166; 167]. The phytochemical composition of the
ingredients (without cinnamic alcohol and rosiridin) is similar to that of Rh. rosea [168]. Rhodiola
kirilowii is a Chinese medicinal herb. Roots and rhizomes extracts are used in Asiatic medicine
independently of their adaptogenic properties also as antimicrobial and anti-inflammatory
drugs [169, 170]. Rhodiola sacra grow in the Changbai Mountain area, Tibet and Xinjiang
autonomous regions in China. In Tibetan folk medicine, Rhodiola Radix is used as a hemostatic,
tonic and contusion releaf factor. Positive effects on learning and memory have been reported,
too [171, 172]. Rhodiola crenulata is distributed in the high cold region of the Northern Hemi‐
sphere in the high plateau region of southwestern China, especially the Hengduan Mountains
region including eastern Tibet, northern Yunnan and western Sichuan. It has strong activities
of anti-anoxia, antifatigue, anti-toxic, anti-radiation, anti-tumour, anti-aging, and active-
oxygen scavenging [173, 174]. Rhodiola sachalinesis A. Bor. is used as a drug of “source of
adaptation to environment” in Chinese traditional medicine. Salidroside can effectively
enhance the body’s ability to resist anoxia, microwave radiation, and fatigue. Furthermore, its
effect on extending human life was also found [175]. Rhodiola imbricata Edgew commonly
known as rose root, is found in the high altitude regions (more than 4000 m altitude) of India.
The radioprotective effect, along with its relevant superoxide ion scavenging, metal chelation,
antioxidant, anti-lipid peroxidation and anti-hemolytic activities were evaluated under both
in vitro and in vivo conditions [176]. Rhodiola iremelica Boriss. – is an endemic plant of Middle
and South Ural mountain. It is included in the Red Book of Republic of Bashkortostan
(Bashkiria) in the category of rare and endangered species. Rh. iremelica is located in places
with different climatic conditions making them unique [177].
Despite the incontestable/undisputed interest to Rh. rosea and the wide intensive research
in phytochemistry, the potential area of the plant biotechnologies, remains less studied and
exploited in comparison to other medicinal  species.  Some of the researchers studied the
possibility  for  induction  of  calli  cultures,  biotransformation  and  organogenesis.  Other
authors  focus  their  research  on  Rhodiola  potential  for  regeneration  and  investigation  of
biologically active substances. Experiments are focused mainly in two directions: 1) looking
for  possibilities  for  in  vitro  synthesis  of  valuable  metabolites  and/or  2)  establishment  of
effective systems for micropropagation, for reintroduction of the plant in nature or in the
field for protection of the species.
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Pioneer experiments on golden root in vitro cultures were initiated 20 years ago [178] from a
Russian scientist who described rooting of assimilating of sprouts R. rosea. Later a few other
reports have appeared concerning the effect of culture media composition and of explant type
on the ability for callogenesis, organogenesis and regeneration of R. rosea, as well as other factors
influencing growth and morphogenesis. Using leaf segments Kirichenko et al. [179] studied callus
and regeneration ability for propagation in vitro of rose root while Bazuk et al. [180] focused on
the rooting potential of shoots obtained from stem segments with two adjacent leaves. Investi‐
gations that are more detailed were carried using seeds and rhizomes from three ecotypes from
the High Altai and South Ural region, which served as the explant source to study induction of
callogenesis  and organogenesis  [181].  Explant  development  was  observed on MS media
containing various phytoregulators (BAP, IAA, NAA, IBA, 2,4-D). Very high percentage of 86%
of the explants formed abundant calli on MS medium supplemented with 0.1 - 0.2 mg/l IAA. BAP
and IAA in concentrations of 0.2mg/l and 0.1mg/l, respectively, was the optimal combination for
multiple bud formation in Rhodiola rosea from stem segments, while for Rhodiola iremelica the
efficient concentrations were lower—0.1 mg/l BAP and 0.05 mg/l IAA. The processes of effi‐
cient callogenesis and organogenesis were influenced by ecotype differences. Adaptation of
regenerants in vermiculite for two weeks in conditions of high humidity (85–90%) and later in
mixture of soil, peat, and vermiculite in proportion of 1 : 1 : 1 was successful, but with consider‐
able differences in the survival rate (from 10% to 95%). In the later experiments [182], the effect
of 5% or 10% v/v liquid extracts of Rh. rosea extracts on the morphogenic abilities of Rh. rosea and
Rh. iremelica were studied. Different in vitro responses were provoked. Bud induction was
stimulated by the lower concentration and inhibited by the higher ones leading to formation of
8.5 shoots per explant in the first case and 1.1 in the second case.
Unlike the previously described investigations with the Altai ecotype of Rhodiola rosea the
optimal concentrations of the cytokinin BAP were 10–15-fold higher for induction of in vitro
cultures from immature leaves explants from a Tibetan ecotype of golden root [183]. The
authors noted interaction between the growth regulators and the illumination of the cultures.
Two mg/l BA and 0.2 mg/l NAA added to the MS medium stimulated formation of incompact
callus tissue. However, when explants were cultivated under dark conditions, higher concen‐
trations of the same phytoregulators BA (3 mg/l) and NAA (0.25 mg/l) were more efficient. MS
medium containing 2 mg/l BA and 0.25 mg/l NAA induced shoot multiplication while rooting
was induced on MS medium containing 0.5 mg/l or 1 mg/l IAA.
In Bulgaria the first investigations on Rhodiola rosea were on the content of polyfenols and
salidrosid in the local populations in Rila, Pirin and Balkan Mountain [184]. The highest salidrosid
levels in the rhizome and root were found in the plants from Rila Mountain while the lowest ones
in the plants from Pirin Mountain 1.55 % and 0.72 %, respectively. From another side polyphe‐
nols were in highest concentration in rose root from Pirin population. Salidrosid is accumulat‐
ed in roots and rhizomes while polyphenol content is equal in all parts of the plant [185, 186].
Seeds of Rhodiola rosea lose their germination potential for a relatively short perod of time
compared to other species. Stratification is one of the approaches for overcoming this problem.
Revina et al. [187] reported about higher germination up to 75 % after treatment of seeds for one
month at temperatures of 2-4 оС. Other authors confirm the role of stratification [188] and report
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about stimulation of germination up to 50-75 % after subjecting seeds to lower temperatures of
-5оС for a period of 3 months [189]. Dimitrov et al. [190] applied a new approach for in vitro
cultivation of seeds. Golden root germination of seeds started on the 7th day of cultivation and
lasted until the 40th day reaching from 37.5% to 97.0% depending on media composition.
Germination was stimulated when seeds were cultured on MS basal medium enriched with
50-100 mg/l giberrellic acid. These high concentrations of GA3 enhanced germination while lower
concentrations of 5-25 mg/l GA3 favored obtaining of seedlings with bigger size [43].
The initial investigations for establishment of golden root in viro cultures in Bulgaria were
dedicated to find out a suitable ecotype for in vitro experiments [190 – 192]. Tasheva et al. [193,
194] optimized seed germination in vitro and later report the first successful results for in
vitro propagation of Rhodiola rosea. A large number of explants isolated from in vitro seedlings
(stem segment with leaf node, apical bud, explants excised from the seedling root basal area)
and in vivo plant (apical bud, adventitious shoots, stem expalnt, rhizome buds, rhizome
segments) were used to study in vitro response [195] on Murashige and Skoog (MS) basal
medium containing various hormonal combinations including benzyladenine, kinetin, zeatin,
2-ip etc. In vitro development led to formation of plantlets, leaf rosette, various type of callus
(compact green, pale, soft liquidy) and callus degeneration without bud formation. The
authors observed that the explants of seedling and apical bud are more suitable for mass clonal
propagation. Multiple shoots proliferation from leaf node explants was most effective on
nutrient medium containing 1.0 or 2.0 mg/l zeatin, 0.1 mg/l IAA and 0.4 mg/l GA 3 (Figure 3
a, Figure 3 b). Rooting in vitro proved to be the most efficient on nutrient medium containing
IBA (2.0 mg/l), IAA (0.2 mg/l) and GA3 (0.4 mg/l) [195]. Interestingly, it was observed that the
coefficient of propagation varied during the different seasons. Highest level of proliferation
was recorded in May-June, when the mean number of shoots per explant was 6.78, while
during the cold seasons multiplication was relatively lower with 2.11 shoots per explant [196].
Adaptation of obtained plants was done under controlled conditions in a cultivation room for
2-3 months and later grown plants were transferred to green house, where survival rate
reached high levels of 85% (Figure 3 c). After 6 months, these regenerants were rooted in natural
conditions in the Rhodopes Mountains experimental field where the survival rate was 68%,
after winter has passed. In April, vigorous vegetation was observed with formation of sprouts,
floweres, seeds and rhizomes like plants in their natural environment.
Genetic stability of in vitro regenerated plants is very important for micropropagation aiming
production of elite plant material or conservation of the species. Chromosome number in the
root tip cells of in vitro regenerats of Rhodiola rosea was examined. All the plantlets though
obtained on different media had 22 chromosomes which number was identical with the diploid
chromosome number of 2n = 22 of the wild plant. These results indicate that the regeneration
schemes developed by authors [197] favor stability of the initial caryotype. This fact is very
important for the purposes of restoration of the species and for creating nurseries and fields
of Golden root serving the pharmacological needs.
Another very important fact is the ability of in vitro obtained plants to synthetize salidroside
what was confirmed by the analysis of one and two years old regenerants. Salidroside content
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in all the samples taken from the roots of regenerants reintroduced in nature was higher than
those in plants, which developed from seeds in the mountains [198].
Roots and rhizome from one year old plant regenerants growing in the green house have lower
salidroside content compared to the plants growing in the experimental field in the mountains
at an altitude of 560 m. However, at the same conditions high levels of rosavin 3.2 % and 3.3
% were detected in green house plants and in mountain plants, respectively (unpublished
data). Golden root extracts used in major part of the clinical research are standardized to 3.0
% of rozavins and 0.8% salidroside, which is a ratio of 3:1. This ratio was 10.75:1 in the
experiments of the authors (unpublished data) for green house one year old regenerants.
Similarly one and three years old regenerants growing in the mountains had higher portion
of rozavins compared to salidroside (1 : 8.6 and 1 : 3.75, respectively) which was very positive
fact (unpublished data)
Recently replanting of Rhodiola rosea regenerants in natural conditions was reported from other
authors, too [199] but unlike the previous report [43] reintroduced regenerants differ mor‐
phologically. Several types of explants and nutrient media were used to reveal the morpho‐
genic potential suitable for elaborating shemes for micropropagation [199]. The most efficient
combinations were when explants from shoot nodes and apices were cultured on MS medium
containing 2.0 mg/l NAA, followed by hormone free MS, then KN (1 mg/l kinetin and 0.5 mg/
l NAA), and AZ (0.2 mg/l IAA and 2 mg/l zeatin). The in vitro generated neo plantlets reached
survival rate over 90% after transfer to septic environment in a hydroponic system for 5-7 days.
After acclimatization, the regenerants were potted into soil until the first summer when they
were transferred to their native habitat (at 1750 m altitude in Ceahlău Mountains, Romania).
During the next summer about 73.5 % of the few dozens of reintroduced regenerants survived.
This percentage dropped at 57 % during the third year. It was observed that the in vitro
regenerants of Rh. rosea developing in their natural habitat differed in leaf color (light green),
compared to the native individuals of this region (green- grey).
For the first time an original protocol for in vitro micropropagation of Rhodiola rosea in a RITA
bioreactor system was reported [200]. Three clones were obtained from in vitro germinated
seedlings of wild Finland golden root. Stimulation of organogenesis was studied using
thidiazuron and zeatin. Two to four μM thidiazuron stimulated shoot induction but inhibited
shoot growth while 1-2 μM zeatin favored shoot growth and leaf number per shoot. Multipli‐
cation rate of the clones differed significantly but the most efficient was obtained on solidified
medium enriched with 2 μM zeatin. In the bioreactor 0.5 μM thidiazuron maintained rapid
shoot proliferation but induced hyperhydracity at higher concentrations. However, hyperhy‐
dracity was abolished when shoots were transferred for 4 weeks on gelled medium enriched
with 1-2 μM zeatin. Shoots formed roots for 5-6 weeks on medium without phytoregulators.
Regenerants transferred to soil in the green hause surved at high rate (85–90%) and after
acclimatization had normal shoot and leaf morphology.
After establishment of reliable Rhodiolain vitro cultures, research has continued for their
implementation for practical use like production of valuable secondary metabolites in
bioreactors, for biotransformation, for manipulation of the metabolic pathways and metabolic
engineering. Biotransformation is a key mechanism to increase production of the biologically
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active compounds in callus cultures. There are few reports on golden root callus cultures with
acompaning analysis of their biologically active metabolites and description of the parameters
for their efficient synthesis in vitro. The first attempts dated a decade ago [201]. Callus was
induced on leaf explants of Rhodiola rosea and transferred into MS liquid medium. Thus
obtained suspension culture was used to to study the possibility to increase synthesis of rosavin
and other cinnamyl glycosides. In the cells for about 3 days, more than 90% of the added
transcinnamyl alcohol (optimal concentration of 2.5 mM) was transformed into various
unidentified products. However, one of them, 3-phenyl-2-propenyl-O-(6′-O-α′-L-arabinoryr‐
anosyl)-β-D-glucopyranoside, found in the intracellular spaces, both of green and yellow
strains of cell cultures, was defined as potential rozavin by very precise methods.
Biotransformation was used for increasing of biologically active substances production in
callus culture in Rhodiola rosea. The effect of different precursors of biologically active sub‐
stances on the biomass and the metabolite production was studied in Rhodiola rosea compact
callus aggregates in liquid medium [202, 203]. Cinnamyl alcohol concentrations up to 0.1 mM
in media did not bring to a significant deviation from the control; 2 to 5 mM changed slightly
callus color from dark to light green. In these cultures rosin content was elevated to 1.25 % dry
weight while rosavin was 0.083% dry weight. Cinnamyl alcohol induced synthesis of four new
products, too. Tyrosol from 0.05 mM and 2 mM did not influence callus growth while
concentrations of 3 mM up to 9 mM caused decrease in biomass production. Two mM of tyrosol
were the optimal levels for salidroside production reaching 2.72 % dry weight. Addition of
glucose had no positive effect on salidroside accumulation but doubled the rosin production.
 
(a) (b) (c) 
Figure 3. In vitro regenerants of Rhodiola rosea Bulgarian ecotype: (a) and (b) – propagated plants on MS medium
enriched zeatin; (c) – two years old regenerants growing in green house.
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Callus tissues cultivated on solid media could produce active substances characteristic for the
species [204] Rh. rosea Addition of yeast extract in the media doubled salidroside content (from
0.8 % to 1.4) and was twice as high as in five-year-old roots of the intact plants. In the later
experiments [205] Rh. rosea callus induced from axillary buds or from seedling hypocotyls
transformed exogenous cinnamyl alcohol into rosin. However, the biotransformation process
was more efficient in the hypocotyl callus where the application of 2.5 mM cinnamyl alcohol
resulted in the increase of rosin content up to 1056.183 mg/100 g on solid medium and 776.330
mg/100 g in liquid medium. Callus tissue obtained from axillary buds and treated in the same
way produced rosavin in a higher concentration of 92.801 mg/100 g and reached 20% of the
amount produced by roots [206].
Krajewska-Patan et al. and György et al. [205, 202, 203] obtained and maintained callus from
Rh. rosea in liquid medium adding different precursors of the biologically active substances to
increase the synthesis of the substances from the main biologically active complex.
The same Bulgarian group successfully established callus cultures, too [207]. Induction of
callogenesis was achieved from leaf explants, isolated from in vitro propagated plants, on
MS media enriched with BAP in concentration from 0.5 mg/l to 2.0 mg/l; 2-iP—0.3 and 3.0
mg/l;  2,4-D—from 0.1  to  2.0  mg/l;  IAA—0.2,  0.3  and 1.0  mg/l;  NAA—0.5,  1.0,  1.5  mg/l;
glutamine—150 mg/l and casein hydrolysate 1000 mg/l.  The highest response of 62.85 %
and 73.17 % formation of callus was observed on two media, both containing 1 mg/l BAP
and either 1 mg/l or 0.5 mg/l 2,4-D (Figure 4 a, b, c, d, e, f,  g, h). The authors observed
(unpublished data)  that  when calli  were cultured on media with the same phytoregula‐
tors  as  mentioned  above  but  with  higher  content  of  sucrose  (3  %  instead  of  2  %)  the
induction of of callogenesis was several folds lower and variations in callus structure and
color were noted. Sucrose concentration influenced synthesis of biologically active substan‐
ces.  Phytochemical analysis revealed that at  2 % sucrose in the medium salidroside and
rozavins were not detected in the calli (unpublished data)
Similar investigations were performed with other Rhodiola species. Rh. sachalinesis calli
cultured with 5% sucrose produced high salidrosid content (0.41 % on the basis of dry wt) than
normal root (0.17 %) [208]. A compact callus aggregate strain and culturing system for high
yield salidroside production was established in Rhodiola sachalinensis [209].
Organogenic callus was obtained from leaves with efficiency of 88.33 % [210]. Among the
yellow, green, and red colored calli, only green callus formed buds though with poor efficiency.
Despite this, regenerated plantlets were rooted on half strength MS medium. Experiments with
Rhodiola sachalinesis proved that cryopreservation of calli is possible followed by successful
recovery of fresh and green tissues for 6 weeks. Isolation of protoplasts was also reported for
this species [211].
in vitro cultures were obtained from Rh. crenulata, Rh. yunnanensis, Rh. fastigata [212, 213] and
Rh. quadrifida [214] proving the role and interactions of the explant type, genotype and
phytohormones for the efficiency of in vitro response and regeneration was also function of
the genotype and the phytohormones. The authors underlined the role of 2,4-D and BA for
production of biologically active substances. Similar observations about the role of the explant,
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Figure 4. Various callus cultures induced on MS basal medium enriched with: (a) – BAP (1 mg/l), 2,4-D (1 mg/l) and
3% sucrose; (b) - BAP (1 mg/l), 2,4-D (1 mg/l) and 2% sucrose; (c) – BAP (1 mg/l), 2,4-D (0.5 mg/l) and 3% sucrose; (d)
– BAP (1 mg/l), 2,4-D (0.5 mg/l) and 2% sucrose; (e) – BAP (1 mg/l), 2,4-D – 1 mg/l, Casein hydrolysate 1000 mg/l and
3 % sucrose; (f) – BAP (1 mg/l), 2,4-D – 1 mg/l, Casein hydrolysate 1000 mg/l and 2 % sucrose (g) – BAP (1 mg/l), NAA
(0.5 mg/l), Casein hydrolysate 1000 mg/l and 3% sucrose; (h) BAP (1 mg/l), NAA (0.5 mg/l), Casein hydrolysate 1000
mg/l and 3% sucrose;
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the temperature of cultivation and the pretreatment duration on salidroside synthesis in
Rhodiola kirilowii callus were made by others [215].
Genetic transformation opens new perspectives for production of biologically active com‐
pounds. Hairy roots induced by Agrobacterium rhizogenes grow faster accumulating greater
biological material. Genetic transformation of Rhodiola sachalinensis was performed with
Agrobacterium rhizogenes [216, 217]. The authors studied conditions for high salidroside
production (the major compounds from the roots of Rhodiola sachalinensis) when precursors
(tyrosol, tyrosine, and phenylalanine) and elicitors (Aspergillus niger, Coriolus versicolor, and
Ganoderma lucidum) were added into the medium. For high salidroside production, the optimal
light intensity, pH value and nitrogen levels were determined, too. The optimal concentration
for the elicitor was 0.05 mg/l while the optimal concentration of the precursor was 1 mmol/l.
The 1000 lx scatter light, pH 4.5 - 4.8, and nitrogen (NH4+: NO3- =1:1) concentration of 80 mmol/
l were the optimal condition for salidrosid production. Authors conclude that hairy roots can
be used as alternative material for the production of secondary metabolites of pharmaceutical
value in Rhodiola.
Examples, given here, though covering a small part of the enormous and tedious work on
medicinal plants, and more particularly on representatives of the genera of Gentiana, Leuco‐
jum and Rhodiola, which are protected in Bulgaria, could give impression on the potential of
different spheres of plant biotechnology (Table 1). The most promising ones being in vitro
clonal propagation of endangered species to create in vitro and ex situ collections, and for
obtaining of raw material and valuable compounds (Figure 5).
Figure 5. Relative share of the achievements in different spheres of biotechnology in the three genera: Gentiana, Rho‐
diola, Leucojum.






















G. lutea yes yes Yes yes yes yes yes
G. kurroo yes yes Yes yes yes yes yes
G. cruciata yes Yes yes yes yes
G. pannonica yes
G. punctata Yes yes yes yes yes
G. straminea Maxim. yes
G. crassicaulis, yes
G. dinarica Beck, Yes yes yes yes
G. corymbifera, Yes yes yes
G. pneumonanthe yes yes yes




G. scabra yes yes
G. acaulis Yes yes yes
G. tibetica yes
G. dahuria Yes yes yes yes yes
G. triflora yes
G. ligularia yes
G. cerina yes yes
G. asclepiadea Yes yes




Rh. sachalinensis yes yes yes
Rh. yunnanensis yes
Rh. iremelica yes Yes yes
Rh. fastigata yes
Rhodiola coccinea yes yes
Leucojum aestivum yes yes Yes yes yes yes yes yes
Table 1. Examples of biotechnological achievements in Gentiana, Rhodiola and Leucojum species.
9. Conclusions
Presented data and results in this chapter aimed at enlightening the potential of plant bio‐
technologies in protection of valuable plant species, including the medicinal ones, which have
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become rare or are close to extinction as a result of the intensive industrialization, urban
economy and climatic changes. One of the measures for overcoming this global problem could
be the cultivation of valuable medicinal plants in experimental conditions. For this purpose
along with the traditional methods for cultivation fields and nurseries, “green” biotechnolo‐
gies can be used. Many scientists have realized that plant biotechnology is an important tool
for multiplication and conservation of the endangered and rare populations of medicinal
plants. Using environmental friendly in vitro technologies a great number of identical plants,
can be propagated, regenerated and transferred back in nature thus restoring and expanding
wild habitats. From another hand, the areas of the medicinal plants will be less subjected to
vulnerable exploitation if the valuable raw material could be obtained by alternative means.
In this sense by micropropagation of plants, enormous amounts of biomass can be produced
continuously and/or for short period of time. In addition, production of biologically active
substances in laboratory conditions contributes to less utilization of the natural resources and
thus protecting the species. The fact that in vitro cultures, cells, tissues, organs and plantlets
can produce metabolites, specific for the intact donor plant, is of tremendous importance for
production of desired compounds. Development of more sophisticated instrumentation and
original approaches allowing biotransformation and metabolic engineering is a revolutionary
step for high technological production of valuable substances and biologically active com‐
pounds demanded from the food, nutraceutical, pharmaceutical and cosmetic industries.
Nomenclature
MS – Murashige and Skoog medium, 1962; BAP – N6-benzylaminopurine; IAA – Indolyl-3-
acetic acid; 2-iP – 6-(y,y-dimethylallyl amino) purine; 2,4-D – 2,4- dichlorophenoxyacetic acid;
NAA - α- naphthyl acetic acid; TDZ – Thidiazuron; Kin – Kinetin; GA3 – Gibberellic acid; IBA
– Indole 3-butyric acid
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